Details for Accession #: Q15637


Protein Sequence










Peptide Information

ID Peptide Seq Site Residue Position in Peptide Position in Protein
3481 MAELGEAPVPASVGSTSGPATTPL T 332
3482 MAELGEAPVPASVGSTSGPATTPL T 338
3483 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 315
3484 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 331
3485 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 333
3486 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR T 337
3487 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 342
3488 QQQQQQPPPPPPPSSSMASSTPL T 521
10001006 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 328
10003060 328
10005398 EYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 17 328
10005528 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 328
10008975 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 7 315
10009031 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 328
10010189 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 328
10011479 YLSLMAELGEAPVPASVGSTSGPATTPLASA S 328
10015298 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 328
10020890 328
10023218 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 8 315
10025344 EYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 17 328
10025962 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 328
10026602 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 7 315
10026783 EYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 4 315
10028162 EYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 17 328
10028799 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 328
10029154 EYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 17 328
10029699 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 328
10030218 S 328
10030794 EYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 331
10030795 EYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 4 315
10030796 EYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 31 342
10036495 RLNTREFR T 96
10036496 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 328
10037507 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR 328

O-GlcNAcylation Information

ID Method Analytical Throughput Ambiguity Species Sample Type Condition log2Ratio P Value Data Source PMID Comments
3481 MS HTP ambiguous human T cells 29351928
3482 MS HTP ambiguous human T cells 29351928
3483 MS HTP ambiguous human T cells 29351928
3484 MS HTP ambiguous human T cells 29351928
3485 MS HTP ambiguous human T cells 29351928
3486 MS HTP ambiguous human T cells 29351928
3487 MS HTP ambiguous human T cells 29351928
3488 MS HTP ambiguous human T cells 29351928
10001006 MS HTP unambiguous human HeLa cells 20 uM GalNAz/200 uM GalNAz 2.083333333 30059200
10003060 MS HTP unambiguous human colorectal cancer (CRC) cell lines SW620 cells/SW480 cells 0.806753924 0.001357461 35254053
10005398 MS HTP unambiguous human HEK 293T cells glucose-deprived/glucose-sufficient 0.665 37541260
10005528 MS HTP unambiguous human HEK 293T cells glucose-deprived/glucose-sufficient 0.75 37541260
10008975 MS HTP unambiguous human HeLa cells 28604694
10009031 MS HTP unambiguous human HeLa cells 28604694
10010189 MS HTP unambiguous human T cells 29351928
10011479 MS HTP unambiguous human HeLa cells 30059200
10015298 MS HTP unambiguous human HeLa cells 31492838
10020890 MS HTP unambiguous human HeLa cells 34161081
10023218 MS HTP unambiguous human HeLa cells 34846842
10025344 MS HTP unambiguous human HeLa cells 35254053
10025962 MS HTP unambiguous human HeLa cells 35254053
10026602 MS HTP unambiguous human HeLa cells 35254053
10026783 MS HTP unambiguous human HeLa cells 35254053
10028162 MS HTP unambiguous human SW480 cells 35254053
10028799 MS HTP unambiguous human SW480 cells 35254053
10029154 MS HTP unambiguous human SW620 cells 35254053
10029699 MS HTP unambiguous human SW620 cells 35254053
10030218 MS HTP unambiguous human SW480 cells, SW620 cells SW620/SW480 0.806753924 0.001357461 35254053
10030794 MS HTP unambiguous human HeLa cell nucleus 35289036
10030795 MS HTP unambiguous human HeLa cell nucleus 35289036
10030796 MS HTP unambiguous human HeLa cell nucleus 35289036
10036495 MS HTP unambiguous human HEK 293T cells 30620550
10036496 MS HTP unambiguous human HEK 293T cells 30620550
10037507 MS HTP unambiguous human HepG2 cells orafenib sensitive/resistant -1 30620550 Peptide quantification value was applied to each modification site

ID Peptide Seq Site Residue Position in Peptide Position in Protein Method Analytical Throughput Ambiguity Species Sample Type Data Source PMID Comments
3481 MAELGEAPVPASVGSTSGPATTPL T 332 MS HTP ambiguous human T cells 29351928
3482 MAELGEAPVPASVGSTSGPATTPL T 338 MS HTP ambiguous human T cells 29351928
3483 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 315 MS HTP ambiguous human T cells 29351928
3484 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 331 MS HTP ambiguous human T cells 29351928
3485 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 333 MS HTP ambiguous human T cells 29351928
3486 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR T 337 MS HTP ambiguous human T cells 29351928
3487 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 342 MS HTP ambiguous human T cells 29351928
3488 QQQQQQPPPPPPPSSSMASSTPL T 521 MS HTP ambiguous human T cells 29351928
10001006 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 328 MS HTP unambiguous human HeLa cells 30059200
10003060 328 MS HTP unambiguous human colorectal cancer (CRC) cell lines 35254053
10005398 EYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 17 328 MS HTP unambiguous human HEK 293T cells 37541260
10005528 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 328 MS HTP unambiguous human HEK 293T cells 37541260
10008975 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 7 315 MS HTP unambiguous human HeLa cells 28604694
10009031 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 328 MS HTP unambiguous human HeLa cells 28604694
10010189 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 328 MS HTP unambiguous human T cells 29351928
10011479 YLSLMAELGEAPVPASVGSTSGPATTPLASA S 328 MS HTP unambiguous human HeLa cells 30059200
10015298 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 328 MS HTP unambiguous human HeLa cells 31492838
10020890 328 MS HTP unambiguous human HeLa cells 34161081
10023218 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 8 315 MS HTP unambiguous human HeLa cells 34846842
10025344 EYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 17 328 MS HTP unambiguous human HeLa cells 35254053
10025962 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 328 MS HTP unambiguous human HeLa cells 35254053
10026602 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 7 315 MS HTP unambiguous human HeLa cells 35254053
10026783 EYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 4 315 MS HTP unambiguous human HeLa cells 35254053
10028162 EYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 17 328 MS HTP unambiguous human SW480 cells 35254053
10028799 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 328 MS HTP unambiguous human SW480 cells 35254053
10029154 EYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 17 328 MS HTP unambiguous human SW620 cells 35254053
10029699 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 328 MS HTP unambiguous human SW620 cells 35254053
10030218 S 328 MS HTP unambiguous human SW480 cells, SW620 cells 35254053
10030794 EYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 20 331 MS HTP unambiguous human HeLa cell nucleus 35289036
10030795 EYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 4 315 MS HTP unambiguous human HeLa cell nucleus 35289036
10030796 EYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 31 342 MS HTP unambiguous human HeLa cell nucleus 35289036
10036495 RLNTREFR T 96 MS HTP unambiguous human HEK 293T cells 30620550
10036496 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR S 328 MS HTP unambiguous human HEK 293T cells 30620550
10037507 MDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPR 328 MS HTP unambiguous human HepG2 cells 30620550 Peptide quantification value was applied to each modification site